ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Common Stock

The latest common stock for LSPRU is $1.6M as of March 2026. That compares with $510K in the prior-year period — up 214.8% year over year. Investors often review this figure alongside ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LSPRU's common stock moved from $510K to $1.6M — a 214.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s operating scale or balance-sheet position.

A common stock figure of $1.6M for LSPRU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LSPRU's common stock ($1.6M), review year-over-year change from $510K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.